Yahoo
HKSE - Delayed Quote HKD

Shandong Weigao Group Medical Polymer Company Limited (1066.HK)

3.345 -0.135 (-3.88%)
At close: 4:08:01 PM GMT+8
Chart Range Bar
Loading chart for 1066.HK
  • Previous Close 3.480
  • Open 3.355
  • Bid 3.340 x --
  • Ask 3.345 x --
  • Day's Range 3.275 - 3.515
  • 52 Week Range 2.920 - 6.880
  • Volume 31,321,876
  • Avg. Volume 22,427,009
  • Market Cap (intraday) 14.87B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 8.16
  • EPS (TTM) 0.410
  • Earnings Date Aug 25, 2026
  • Forward Dividend & Yield 0.14 (3.95%)
  • Ex-Dividend Date Oct 21, 2026
  • 1y Target Est 5.75

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

www.weigaogroup.com

13,307

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 8/26/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1066.HK
32.03%
HANG SENG INDEX (^HSI)
0.09%

1-Year Return

1066.HK
49.08%
HANG SENG INDEX (^HSI)
0.50%

3-Year Return

1066.HK
52.24%
HANG SENG INDEX (^HSI)
41.58%

5-Year Return

1066.HK
70.86%
HANG SENG INDEX (^HSI)
0.93%

Analyst Insights

View More

Analyst Price Targets

3.93
5.75 Average
3.345 Current
8.17 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/25/2026
  • Market Cap

    15.47B

  • Enterprise Value

    10.40B

  • Trailing P/E

    8.52

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.01

  • Price/Book (mrq)

    0.55

  • Enterprise Value/Revenue

    0.67

  • Enterprise Value/EBITDA

    2.72

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.14%

  • Return on Assets (ttm)

    3.14%

  • Return on Equity (ttm)

    5.68%

  • Revenue (ttm)

    13.59B

  • Net Income Avi to Common (ttm)

    1.38B

  • Diluted EPS (ttm)

    0.410

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.49B

  • Total Debt/Equity (mrq)

    15.57%

  • Levered Free Cash Flow (ttm)

    1.23B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: